Palavra-chave: IMATINIB

RNAS DISCONTINUATION CHRONIC MYELOID LEUKAEMIA BCR-ABL PHARMAECONOMIC STUDY LEUCEMIA MIELOIDE CRÔNICA START OBSERVATIONAL LOW EDUCATION LEVEL CML BCR/ABL GENE LEUCEMIA MIELÓIDE CRÔNICA FRONTLINE MESILATO EUTOS SCORE ANEMIA FALCIFORME CHRONIC MYELOGENOUS LEUKEMIA BRAZIL KIT K5091 MOLECULAR RESPONSE CHRONIC MYELOID LEUKEMIA CYTARABINE IRS-1 CYTOGENETIC REMISSION OCULAR BCR/ABL CHRONIC MEYLOID LEUKEMIA LEUCEMIA MIELÓDE CRÔNICA CHRONIC MYELOID LEUCEMIA (CML) STEM CELL TRANSPLANTATION GENERIC PROTEIN-CODING CITARABINA CML-CP POLYMORPHISMS CHILDREN AND ADOLESCENTS MOLECULAR FIRST-LINE TRANSPORTER GENES CHRONIC PHASE DASATINIB-TREATED CRONIC LYMPHOCYTIC LEUKEMIA DASATINIB MITOXANTRONE LEUCEMIA MIELÓIDE CRÔNICA (LMC) CHRONIC MYELOID LEUCEMIA NON-MYELOABLATIVE LASOR K562 CELLS CYTOGENETIC NILOTINIB MR4.5 LALNET BCR-ABL MUTATIONS PHASE 2 BCL/ABL LEUCEMIA MIELÓIDE CRÔNICA (LMC-PB) F359V MYELOGENOUS LEUKEMIA TYROSINE KINASE INHIBITORS TREATMENT-FREE REMISSION